Page last updated: 2024-08-17

1,2,3,4-tetrahydroisoquinoline and Invasiveness, Neoplasm

1,2,3,4-tetrahydroisoquinoline has been researched along with Invasiveness, Neoplasm in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Härkönen, P; Hedblom, A; Johansson, ME; Larsson, R; Miftakhova, RR; Persson, JL; Sarwar, M; Semenas, J; Shcherbina, L; Sterner, O1

Other Studies

1 other study(ies) available for 1,2,3,4-tetrahydroisoquinoline and Invasiveness, Neoplasm

ArticleYear
The role of PI3K/AKT-related PIP5K1α and the discovery of its selective inhibitor for treatment of advanced prostate cancer.
    Proceedings of the National Academy of Sciences of the United States of America, 2014, Sep-02, Volume: 111, Issue:35

    Topics: Animals; Apoptosis; Cell Proliferation; Cell Survival; Diketopiperazines; Disease Models, Animal; Drug Discovery; Humans; Indoles; Isoquinolines; Male; Mice; Neoplasm Invasiveness; Phosphatidylinositol 3-Kinases; Phosphotransferases (Alcohol Group Acceptor); Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Signal Transduction; Tetrahydroisoquinolines; Xenograft Model Antitumor Assays

2014